The purpose of this Notice of Special Interest (NOSI) is to support research on the discovery and characterization of Inborn Errors of Immunity (IEIs), also referred to as Primary Immunodeficiencies, to understand the causes and mechanisms of disease, enable early detection and molecular diagnosis, and support the development of strategies to treat and eventually cure these disorders.
Innovations in whole genome sequencing and other high throughput technologies have led to more rapid discovery of novel genes and molecular pathways responsible for aberrant or sub-optimal immune responses, leading to enhancement of infection or other immune-mediated diseases. Identification of genes and pathways associated with IEIs should inform discovery and development of novel diagnostic methods to inform personalized approaches for therapies.
This NOSI will support research on the following topics of IEIs:
This notice applies to due dates on or after June 5, 2024 and subsequent receipt dates through March 16, 2027 .
NOT-AI-24-024
Sponsor Institute/Organizations: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Oct 05, 2024
Varies
Affiliation: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.